Literature DB >> 18239313

Anticancer constituents from the roots of Rubia cordifolia L.

Jong Keun Son1, Soon Ja Jung, Ji Hyun Jung, Zhe Fang, Chong Soon Lee, Chang Seob Seo, Dong Cheul Moon, Byung Sun Min, Mi Ryeo Kim, Mi Hee Woo.   

Abstract

Activity-directed isolation of the methylene chloride fraction of the roots of Rubia cordifolia L. resulted in the identification of a new epoxymollugin (3) and eight known compounds (1, 2, 4-9). The structures of the compounds were elucidated from chemical and spectroscopic evidence. In addition, their topoisomerase I and II inhibitory activities and cytotoxicities were measured.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18239313     DOI: 10.1248/cpb.56.213

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  16 in total

1.  Synthesis of novel and diverse naphtho[1,2-b]furans by phosphine-catalyzed [3+2] annulation of activated 1,4-naphthoquinones and acetylenecarboxylates.

Authors:  Likai Xia; Krishna Bahadur Somai Magar; Yong Rok Lee
Journal:  Mol Divers       Date:  2014-10-01       Impact factor: 2.943

Review 2.  Journey of anthraquinones as anticancer agents - a systematic review of recent literature.

Authors:  M Shaheer Malik; Reem I Alsantali; Rabab S Jassas; Abdulrahman A Alsimaree; Riyaz Syed; Meshari A Alsharif; Kulkarni Kalpana; Moataz Morad; Ismail I Althagafi; Saleh A Ahmed
Journal:  RSC Adv       Date:  2021-11-05       Impact factor: 4.036

3.  Re2O7-catalyzed formal [3 + 2] cycloaddition for diverse naphtho[1,2-b]furan-3-carboxamides and their biological evaluation.

Authors:  Likai Xia; Akber Idhayadhulla; Yong Rok Lee
Journal:  Mol Divers       Date:  2015-08-11       Impact factor: 2.943

4.  Secondary metabolites as DNA topoisomerase inhibitors: A new era towards designing of anticancer drugs.

Authors:  Supriya Baikar; Nutan Malpathak
Journal:  Pharmacogn Rev       Date:  2010-01

Review 5.  Phytochemicals and Biogenic Metallic Nanoparticles as Anticancer Agents.

Authors:  Pasupuleti Visweswara Rao; Devi Nallappan; Kondeti Madhavi; Shafiqur Rahman; Lim Jun Wei; Siew Hua Gan
Journal:  Oxid Med Cell Longev       Date:  2016-02-23       Impact factor: 6.543

6.  Mollugin Has an Anti-Cancer Therapeutic Effect by Inhibiting TNF-α-Induced NF-κB Activation.

Authors:  Zhe Wang; Ming Yue Li; Chunliu Mi; Ke Si Wang; Juan Ma; Xuejun Jin
Journal:  Int J Mol Sci       Date:  2017-07-26       Impact factor: 5.923

Review 7.  Dietary Plants for the Prevention and Management of Kidney Stones: Preclinical and Clinical Evidence and Molecular Mechanisms.

Authors:  Mina Cheraghi Nirumand; Marziyeh Hajialyani; Roja Rahimi; Mohammad Hosein Farzaei; Stéphane Zingue; Seyed Mohammad Nabavi; Anupam Bishayee
Journal:  Int J Mol Sci       Date:  2018-03-07       Impact factor: 5.923

8.  Structural and bioactive studies of terpenes and cyclopeptides from the Genus Rubia.

Authors:  Kuo Xu; Penglong Wang; Bin Yuan; Yatao Cheng; Qiang Li; Haimin Lei
Journal:  Chem Cent J       Date:  2013-05-04       Impact factor: 4.215

9.  Involvement of Nrf2-mediated upregulation of heme oxygenase-1 in mollugin-induced growth inhibition and apoptosis in human oral cancer cells.

Authors:  Young-Man Lee; Q-Schick Auh; Deok-Won Lee; Jun-Yeol Kim; Ha-Jin Jung; Seung-Ho Lee; Eun-Cheol Kim
Journal:  Biomed Res Int       Date:  2013-05-02       Impact factor: 3.411

10.  Cytoprotective effect of 2-carbomethoxy-2,3-epoxy-3-prenyl-1,4-naphthoquinone (CMEP-NQ) is mediated by the inhibition of BAK-dependent mitochondrial apoptosis pathway.

Authors:  Do Youn Jun; Won Young Jang; Ki Yun Kim; Mi Hee Woo; Young Ho Kim
Journal:  PLoS One       Date:  2018-10-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.